Rachel Stevens, FISM News [elfsight_social_share_buttons id=”1″] Johnson & Johnson said on Tuesday it would take a few days at least to hear from a safety monitoring panel about its review of the company’s late-stage COVID-19 vaccine trial after announcing that the large study had been paused due to an unexplained illness in one participant. The […]
- Categories:
- FISM News